Search for Clinical Trial Results
Klatskin Tumor - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma Condition:
|
Recruiting |
Study Name: Best Biliary Drainage Option in Advanced Klatskin Tumor Condition: Cholangitis Date: 2017-03-25 Interventions:
|
Withdrawn |
Study Name: Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study Condition: Cholangiocarcinoma Date: 2008-01-17 |
Withdrawn |
Study Name: Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy Condition:
Date: 2012-03-07 Interventions: |
Withdrawn |
Study Name: Uncovered Self-expandable Metal Stent Versus Double Layer Plastic Stent for Malignant Hilar Stricture Condition:
Date: 2010-05-14 Interventions:
|
Withdrawn |
Study Name: Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma Condition:
Date: 2008-11-24 Interventions: Procedure: Preoperative biliary drainage Percutaneous transhepatic biliary drainage(PTBD) is performed u |
Completed |
Study Name: Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection? Condition:
Interventions: Procedure: Minor or Major Liver Resection |
Recruiting |
Study Name: Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma Condition:
Date: 2016-03-20 Interventions: Procedure: Photodynamic therapy Photolon (Belmedpreparaty, Minsk, Republic of Belarus), was administered |
Recruiting |
Study Name: A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2015-02-23 Interventions: Drug: LDK378 LDK378 750 mg ( p.o.) daily, with 3 week as a treatment cycle. |
Not yet recruiting |
Study Name: Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma Condition: Cholangitis Date: 2017-03-26 Interventions: Procedure: Injection of 37℃ contrast agent Nonionic contrast agent is heated to 37℃ in a inc |